162 related articles for article (PubMed ID: 36238647)
1. Recurrence of Early Hepatocellular Carcinoma after Surgery May Be Related to Intestinal Oxidative Stress and the Development of a Predictive Model.
He Y; Liang T; Chen Z; Mo S; Liao Y; Gao Q; Huang K; Peng T; Zhou W; Han C
Oxid Med Cell Longev; 2022; 2022():7261786. PubMed ID: 36238647
[TBL] [Abstract][Full Text] [Related]
2. Radiomics analysis enables recurrence prediction for hepatocellular carcinoma after liver transplantation.
Guo D; Gu D; Wang H; Wei J; Wang Z; Hao X; Ji Q; Cao S; Song Z; Jiang J; Shen Z; Tian J; Zheng H
Eur J Radiol; 2019 Aug; 117():33-40. PubMed ID: 31307650
[TBL] [Abstract][Full Text] [Related]
3. Radiomic Features at Contrast-enhanced CT Predict Recurrence in Early Stage Hepatocellular Carcinoma: A Multi-Institutional Study.
Ji GW; Zhu FP; Xu Q; Wang K; Wu MY; Tang WW; Li XC; Wang XH
Radiology; 2020 Mar; 294(3):568-579. PubMed ID: 31934830
[TBL] [Abstract][Full Text] [Related]
4. Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: A multi-institutional study.
Ji GW; Zhu FP; Xu Q; Wang K; Wu MY; Tang WW; Li XC; Wang XH
EBioMedicine; 2019 Dec; 50():156-165. PubMed ID: 31735556
[TBL] [Abstract][Full Text] [Related]
5. CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma.
Zhou Y; He L; Huang Y; Chen S; Wu P; Ye W; Liu Z; Liang C
Abdom Radiol (NY); 2017 Jun; 42(6):1695-1704. PubMed ID: 28180924
[TBL] [Abstract][Full Text] [Related]
6. Development of preoperative prognostic models including radiological features for survival of singular nodular HCC patients.
Ding DY; Liu L; Li HL; Gan XJ; Ding WB; Gu FM; Sun DP; Li W; Pan ZY; Yuan SX; Zhou WP
Hepatobiliary Pancreat Dis Int; 2023 Feb; 22(1):72-80. PubMed ID: 35428596
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a Model Including Distinct Vascular Patterns to Estimate Survival in Hepatocellular Carcinoma.
Lin WP; Xing KL; Fu JC; Ling YH; Li SH; Yu WS; Zhang YF; Zhong C; Wang JH; Chen ZY; Lu LH; Wei W; Guo RP
JAMA Netw Open; 2021 Sep; 4(9):e2125055. PubMed ID: 34515782
[TBL] [Abstract][Full Text] [Related]
8. MRI-Based Radiomics: Associations With the Recurrence-Free Survival of Patients With Hepatocellular Carcinoma Treated With Conventional Transcatheter Arterial Chemoembolization.
Song W; Yu X; Guo D; Liu H; Tang Z; Liu X; Zhou J; Zhang H; Liu Y; Liu X
J Magn Reson Imaging; 2020 Aug; 52(2):461-473. PubMed ID: 31675174
[TBL] [Abstract][Full Text] [Related]
9. Novel Models Predict Postsurgical Recurrence and Overall Survival for Patients with Hepatitis B Virus-Related Solitary Hepatocellular Carcinoma ≤10 cm and Without Portal Venous Tumor Thrombus.
Wang XH; Liao B; Hu WJ; Tu CX; Xiang CL; Hao SH; Mao XH; Qiu XM; Yang XJ; Yue X; Kuang M; Peng BG; Li SQ
Oncologist; 2020 Oct; 25(10):e1552-e1561. PubMed ID: 32663354
[TBL] [Abstract][Full Text] [Related]
10. Risk stratification of solitary hepatocellular carcinoma ≤ 5 cm without microvascular invasion: prognostic values of MR imaging features based on LI-RADS and clinical parameters.
Wang L; Feng B; Li D; Liang M; Wang S; Wang S; Ma X; Zhao X
Eur Radiol; 2023 May; 33(5):3592-3603. PubMed ID: 36884087
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.
Fu YP; Yi Y; Huang JL; Jing CY; Sun J; Ni XC; Lu ZF; Cao Y; Zhou J; Fan J; Qiu SJ
Oncologist; 2017 May; 22(5):561-569. PubMed ID: 28438885
[TBL] [Abstract][Full Text] [Related]
12. Macrotrabecular-massive subtype-based nomogram to predict early recurrence of hepatocellular carcinoma after surgery.
Yang Y; Mao S; Fang J; Wang G; Shan Y; Yu X; Lu C
Eur J Gastroenterol Hepatol; 2023 Apr; 35(4):505-511. PubMed ID: 36827535
[TBL] [Abstract][Full Text] [Related]
13. A preoperative model for predicting early recurrence in patients undergoing resection for single hepatocellular carcinoma.
Liu YW; Moi SH; Li WF; Lin CC; Yong CC; Wang CC; Yen YH; Lin CY
Eur J Surg Oncol; 2023 Aug; 49(8):1444-1449. PubMed ID: 36948970
[TBL] [Abstract][Full Text] [Related]
14. A simplified prediction model for early intrahepatic recurrence after hepatectomy for patients with unilobar hepatocellular carcinoma without macroscopic vascular invasion: An implication for adjuvant therapy and postoperative surveillance.
Ng KK; Cheung TT; Pang HH; Wong TC; Dai JW; Ma KW; She WH; Kotewall CN; Lo CM
Surg Oncol; 2019 Sep; 30():6-12. PubMed ID: 31500787
[TBL] [Abstract][Full Text] [Related]
15. Prediction of early recurrence of hepatocellular carcinoma after resection using digital pathology images assessed by machine learning.
Saito A; Toyoda H; Kobayashi M; Koiwa Y; Fujii H; Fujita K; Maeda A; Kaneoka Y; Hazama S; Nagano H; Mirza AH; Graf HP; Cosatto E; Murakami Y; Kuroda M
Mod Pathol; 2021 Feb; 34(2):417-425. PubMed ID: 32948835
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant anti-PD-1 antibody for hepatocellular carcinoma with high recurrence risks after hepatectomy.
Chen W; Hu S; Liu Z; Sun Y; Wu J; Shen S; Peng Z
Hepatol Int; 2023 Apr; 17(2):406-416. PubMed ID: 36645648
[TBL] [Abstract][Full Text] [Related]
17. Comparison of a preoperative MR-based recurrence risk score versus the postoperative score and four clinical staging systems in hepatocellular carcinoma: a retrospective cohort study.
Wei H; Jiang H; Qin Y; Wu Y; Lee JM; Yuan F; Zheng T; Duan T; Zhang Z; Qu Y; Chen J; Chen Y; Ye Z; Yao S; Zhang L; Yang T; Song B
Eur Radiol; 2022 Nov; 32(11):7578-7589. PubMed ID: 35554652
[TBL] [Abstract][Full Text] [Related]
18. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
[No Abstract] [Full Text] [Related]
19. Potential predictive factors for microvascular invasion in hepatocellular carcinoma classified within the Milan criteria.
Imura S; Teraoku H; Yoshikawa M; Ishikawa D; Yamada S; Saito Y; Iwahashi S; Ikemoto T; Morine Y; Shimada M
Int J Clin Oncol; 2018 Feb; 23(1):98-103. PubMed ID: 28875240
[TBL] [Abstract][Full Text] [Related]
20. Validated preoperative computed tomography risk estimation for postoperative hepatocellular carcinoma recurrence.
Zhang W; Lai SL; Chen J; Xie D; Wu FX; Jin GQ; Su DK
World J Gastroenterol; 2017 Sep; 23(35):6467-6473. PubMed ID: 29085196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
